On the other hand, a recent study suggested that a low tumor-infiltrating neutrophil number increased IFNγ signaling and cytotoxic T-cells, thus enhancing the efficacy of anti-PD-(L)1 treatment in NSCLC patients [90]. The gene discussed is IFNG; the disease is neoplasm.